Murdoch D, Lyseng-Williamson KA (2005). "Spotlight on subcutaneous recombinant interferon-beta-1a (Rebif) in relapsing-remitting multiple sclerosis". BioDrugs. ج. 19 ع. 5: 323–5. DOI:10.2165/00063030-200519050-00005. PMID:16207073.
Bates D (يناير 2011). "Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials". Neurology. ج. 76 ع. 1 Suppl 1: S14-25. DOI:10.1212/WNL.0b013e3182050388. PMID:21205678.
Murdoch D, Lyseng-Williamson KA (2005). "Spotlight on subcutaneous recombinant interferon-beta-1a (Rebif) in relapsing-remitting multiple sclerosis". BioDrugs. ج. 19 ع. 5: 323–5. DOI:10.2165/00063030-200519050-00005. PMID:16207073.
Bates D (يناير 2011). "Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials". Neurology. ج. 76 ع. 1 Suppl 1: S14-25. DOI:10.1212/WNL.0b013e3182050388. PMID:21205678.